Normal view MARC view ISBD view

Nuclear retinoid receptors and their mechanism of action. [electronic resource]

By:

Pfahl, M

Contributor(s):

Producer: 19950127Description: 327-82 p. digitalISSN:

0083-6729

Subject(s):

Online resources:

Available from publisher's website

In: Vitamins and hormones vol. 49

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.

Back to results

1 Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs.
by Hargrove, Tatiana Y
2 Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol.
by Hargrove, Tatiana Y
3 Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.
by Hargrove, Tatiana Y
4 Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi.
by Lepesheva, Galina I
5 Sequence variation in CYP51A from the Y strain of Trypanosoma cruzi alters its sensitivity to inhibition.
by Cherkesova, Tatiana S
6 Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
by Hargrove, Tatiana Y
7 Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51.
by Hargrove, Tatiana Y
8 Structural analyses of
by Hargrove, Tatiana Y
9 Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design.
by Hargrove, Tatiana Y
10 Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.
by Lepesheva, Galina I
11 VNI cures acute and chronic experimental Chagas disease.
by Villalta, Fernando
12 Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
by Hargrove, Tatiana Y
13 Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.
by Friggeri, Laura
14 Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition.
by Friggeri, Laura
15 Crystal structures of Trypanosoma brucei sterol 14alpha-demethylase and implications for selective treatment of human infections.
by Lepesheva, Galina I
16 CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds.
by Hargrove, Tatiana Y
17 Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase.
by Konkle, Mary E
18 Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi.
by Hoekstra, William J
19 VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.
by Lepesheva, Galina I
20 Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.
by Friggeri, Laura